I queried the 6% shorts in another thread. My current thought is that they've probably already made a lot shorting from $40 down to current levels. Will they close their positions before FDA approval?
My other thought was whether there is there a patent issue with this drug? I know its been in development for a long time. Will it come off patent soon and we see generics flood the market?
Shorts at 6%, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.36 |
Change
-0.080(0.52%) |
Mkt cap ! $769.1M | |||
| Open | High | Low | Value | Volume |
| $15.62 | $15.63 | $15.36 | $580.8K | 37.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 195 | $15.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.55 | 2023 | 2 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |